These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 8138751)

  • 1. Structure-activity relationships of glucagon-like peptide-1(7-36)amide: insulinotropic activities in perfused rat pancreases, and receptor binding and cyclic AMP production in RINm5F cells.
    Watanabe Y; Kawai K; Ohashi S; Yokota C; Suzuki S; Yamashita K
    J Endocrinol; 1994 Jan; 140(1):45-52. PubMed ID: 8138751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucagon-like peptide-1(7-36)amide: characterization of the domain responsible for binding to its receptor on rat insulinoma RINm5F cells.
    Gallwitz B; Schmidt WE; Conlon JM; Creutzfeldt W
    J Mol Endocrinol; 1990 Aug; 5(1):33-9. PubMed ID: 2168708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effects of various C-terminal and N-terminal fragment peptides of glucagon-like peptide-1 on insulin and glucagon release from the isolated perfused rat pancreas.
    Suzuki S; Kawai K; Ohashi S; Mukai H; Yamashita K
    Endocrinology; 1989 Dec; 125(6):3109-14. PubMed ID: 2684616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of glucagon-like peptide-1(7-36)amide and somatostatin-14 in RINm5F cells and in the perfused rat pancreas.
    Göke R; Fehmann HC; Richter G; Trautmann M; Göke B
    Pancreas; 1989; 4(6):668-73. PubMed ID: 2573056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual glucagon recognition by pancreatic beta-cells via glucagon and glucagon-like peptide 1 receptors.
    Moens K; Flamez D; Van Schravendijk C; Ling Z; Pipeleers D; Schuit F
    Diabetes; 1998 Jan; 47(1):66-72. PubMed ID: 9421376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucagon-like peptide-1 improves insulin and proinsulin binding on RINm5F cells and human monocytes.
    Ebinger M; Jehle DR; Fussgaenger RD; Fehmann HC; Jehle PM
    Am J Physiol Endocrinol Metab; 2000 Jul; 279(1):E88-94. PubMed ID: 10893327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells.
    Göke R; Fehmann HC; Linn T; Schmidt H; Krause M; Eng J; Göke B
    J Biol Chem; 1993 Sep; 268(26):19650-5. PubMed ID: 8396143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptors for glucagon-like peptide-1(7-36) amide on rat insulinoma-derived cells.
    Göke R; Conlon JM
    J Endocrinol; 1988 Mar; 116(3):357-62. PubMed ID: 2832504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic stability, receptor binding, cAMP generation, insulin secretion and antihyperglycaemic activity of novel N-terminal Glu9-substituted analogues of glucagon-like peptide-1.
    Green BD; Gault VA; Irwin N; Mooney MH; Bailey CJ; Harriott P; Greer B; Flatt PR; O'Harte FP
    Biol Chem; 2003 Dec; 384(12):1543-51. PubMed ID: 14719796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding specificity and signal transduction of receptors for glucagon-like peptide-1(7-36)amide and gastric inhibitory polypeptide on RINm5F insulinoma cells.
    Gallwitz B; Witt M; Fölsch UR; Creutzfeldt W; Schmidt WE
    J Mol Endocrinol; 1993 Jun; 10(3):259-68. PubMed ID: 8396943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucagon-like peptide-I analogs: effects on insulin secretion and adenosine 3',5'-monophosphate formation.
    Gefel D; Hendrick GK; Mojsov S; Habener J; Weir GC
    Endocrinology; 1990 Apr; 126(4):2164-8. PubMed ID: 2156683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The entero-insular axis: the new incretin candidate glucagon-like peptide-1(7-36)amide (GLP-1(7-36))amide].
    Göke R; Göke B; Richter G; Arnold R
    Z Gastroenterol; 1988 Nov; 26(11):715-9. PubMed ID: 2849249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the insulinotropic activity of glucagon-superfamily peptides in rat pancreas perfusion.
    Suzuki S; Kawai K; Ohashi S; Watanabe Y; Yamashita K
    Horm Metab Res; 1992 Oct; 24(10):458-61. PubMed ID: 1464409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional receptors for the insulinotropic hormone glucagon-like peptide-I(7-37) on a somatostatin secreting cell line.
    Fehmann HC; Habener JF
    FEBS Lett; 1991 Feb; 279(2):335-40. PubMed ID: 1672112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dipeptidyl peptidase IV resistant analogues of glucagon-like peptide-1 which have extended metabolic stability and improved biological activity.
    Deacon CF; Knudsen LB; Madsen K; Wiberg FC; Jacobsen O; Holst JJ
    Diabetologia; 1998 Mar; 41(3):271-8. PubMed ID: 9541166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A synthetic glucagon-like peptide-1 analog with improved plasma stability.
    Ritzel U; Leonhardt U; Ottleben M; Rühmann A; Eckart K; Spiess J; Ramadori G
    J Endocrinol; 1998 Oct; 159(1):93-102. PubMed ID: 9795346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lys9 for Glu9 substitution in glucagon-like peptide-1(7-36)amide confers dipeptidylpeptidase IV resistance with cellular and metabolic actions similar to those of established antagonists glucagon-like peptide-1(9-36)amide and exendin (9-39).
    Green BD; Mooney MH; Gault VA; Irwin N; Bailey CJ; Harriott P; Greer B; Flatt PR; O'Harte FP
    Metabolism; 2004 Feb; 53(2):252-9. PubMed ID: 14767880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulatory effects of glucagon-like peptides on human insulinoma cells and insulin-releasing clonal RINm5F cells.
    Flatt PR; Shiber O; Hampton SM; Marks V
    Diabetes Res; 1990 Feb; 13(2):55-9. PubMed ID: 1965428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that glucagon stimulates insulin secretion through its own receptor in rats.
    Kawai K; Yokota C; Ohashi S; Watanabe Y; Yamashita K
    Diabetologia; 1995 Mar; 38(3):274-6. PubMed ID: 7758872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Priming effect of glucagon-like peptide-1 (7-36) amide, glucose-dependent insulinotropic polypeptide and cholecystokinin-8 at the isolated perfused rat pancreas.
    Fehmann HC; Göke R; Göke B; Bächle R; Wagner B; Arnold R
    Biochim Biophys Acta; 1991 Feb; 1091(3):356-63. PubMed ID: 1705823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.